RxDoctor Payments Data

Steven Theiss

Orthopaedic Surgery · Birmingham, ALNPI 1922050715

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (46.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Zimmer Biomet at 47.1% of the total. Reporting peaked in 2019 at $11,852 and has fallen 94.3% since, to $675 in 2025.

$18,416in general payments, 2019–2025

Across 69 payments — averaging $266.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$9K
  • Synthes GmbH$5K
  • Stryker$1K
  • Spine Wave, Inc.$704
  • Globus Medical$560
  • Cerapedics Inc.$417
  • plus $2K from 18 others
$9,866in research payments, 2019–2025

Across 11 payments — averaging $896.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$10K

What the payments were for

  • Royalty or licence$8,54046%
  • Consulting fees$5003%
  • Speaking & faculty fees$3,00016%
  • Travel & lodging$1,4748%
  • Food & beverage$4,75126%
  • Education$1501%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,416 in reported general payments places this provider in the 80th percentile of 319 orthopaedic surgery providers in Alabama.

See all orthopaedic surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$169,597
Medicare patients
170
Services billed
504

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin43$670
Oxycodone Hcl25$194
Methocarbamol13$65

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →